fondaparinux sodium
NDC 70710-1514, fondaparinux sodium, injection, solution, from Zydus Pharmaceuticals (USA) Inc..
- Product NDC
- 70710-1514
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208615
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FONDAPARINUX SODIUM2.5 mg/.5mL
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1514-6 | 70710151406 | 10 SYRINGE in 1 CARTON (70710-1514-6) / .5 mL in 1 SYRINGE (70710-1514-2) |
| 70710-1514-9 | 70710151409 | 2 SYRINGE in 1 CARTON (70710-1514-9) / .5 mL in 1 SYRINGE (70710-1514-2) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/dffbf7c9-495e-4a33-ac76-57b52f014fc2Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70710-1514
Use it
Look up 70710-1514 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1514. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.